Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients (Q79777424)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

B-cell chronic lymphocytic leukemia

25 December 2019

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Rosalba Rosato

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Marco Ladetto

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Ricca I

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Rocci A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Francese R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Compagno M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Lobetti Bodoni C

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

De Marco F

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Astolfi M

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Monitillo L

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Vallet S

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Calvi R

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ficara F

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Omedè P

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Gallamini A

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Marinone C

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Bergui L

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Boccadoro M

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Tarella C

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

15 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

697-705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301820%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404544

25 December 2019

exact match

0 references

cites work

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Biology and treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Molecular genetics and its clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Mechanisms of chromosomal translocations in B cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

[Validation of the Düsseldorfer screening tool: a trait-based approach to assess psychological distress of cancer patients]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of UnmutatedVHGene in Patients With Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Comparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Telomere shortening in patients with plasma cell disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Telomerase modulates expression of growth-controlling genes and enhances cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404544

7 January 2021